1 |
Ai, J., Pascal, L.E., O'Malley, K.J., Dar, J.A., Isharwal, S., Qiao, Z., Ren, B., Rigatti, L.H., Dhir, R., Xiao, W., et al. (2014). Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model. Oncogene 33, 2286-2294.
DOI
|
2 |
Backman, S.A., Stambolic, V., Suzuki, A., Haight, J., Elia, A., Pretorius, J., Tsao, M.S., Shannon, P., Bolon, B., Ivy, G.O., et al. (2001). Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat. Genet. 29, 396-403.
DOI
|
3 |
Bernards, R. (2014). Finding effective cancer therapies through loss of function genetic screens. Curr. Opin. Genet. Dev. 24, 23-29.
DOI
|
4 |
Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P.P. (1998). Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348-355.
DOI
|
5 |
Dickins, R.A., McJunkin, K., Hernando, E., Premsrirut, P.K., Krizhanovsky, V., Burgess, D.J., Kim, S.Y., Cordon-Cardo, C., Zender, L., Hannon, G.J., et al. (2007). Tissue-specific and reversible RNA interference in transgenic mice. Nat. Genet. 39, 914-921.
DOI
|
6 |
Fellmann, C., and Lowe, S.W. (2014). Stable RNA interference rules for silencing. Nat. Cell Biol. 16, 10-18.
DOI
|
7 |
Fritsch, L., Martinez, L.A., Sekhri, R., Naguibneva, I., Gerard, M., Vandromme, M., Schaeffer, L., and Harel-Bellan, A. (2004). Conditional gene knock-down by CRE-dependent short interfering RNAs. EMBO Rep. 5, 178-182.
DOI
|
8 |
Groszer, M., Erickson, R., Scripture-Adams, D.D., Lesche, R., Trumpp, A., Zack, J.A., Kornblum, H.I., Liu, X., and Wu, H. (2001). Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294, 2186-2189.
DOI
|
9 |
Gupta, S., Schoer, R.A., Egan, J.E., Hannon, G.J., and Mittal, V. (2004). Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 101, 1927-1932.
DOI
|
10 |
Hitz, C., Wurst, W., and Kuhn, R. (2007). Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference. Nucleic Acids Res. 35, e90.
DOI
|
11 |
Hopkins, B.D., Hodakoski, C., Barrows, D., Mense, S.M., and Parsons, R.E. (2014). PTEN function: the long and the short of it. Trends Biochem. Sci. 39, 183-190.
DOI
|
12 |
Im, E., Jung, J., Pothoulakis, C., and Rhee, S.H. (2014). Disruption of Pten speeds onset and increases severity of spontaneous colitis in Il10(-/-) mice. Gastroenterology 147, 667-679 e610.
DOI
|
13 |
Ittner, L.M., and Gotz, J. (2007). Pronuclear injection for the production of transgenic mice. Nat. Protoc. 2, 1206-1215.
DOI
|
14 |
Kasim, V., Miyagishi, M., and Taira, K. (2004). Control of siRNA expression using the Cre-loxP recombination system. Nucleic Acids Res. 32, e66.
DOI
|
15 |
Kleinhammer, A., Deussing, J., Wurst, W., and Kuhn, R. (2011). Conditional RNAi in mice. Methods 53, 142-150.
DOI
|
16 |
Knobbe, C.B., Lapin, V., Suzuki, A., and Mak, T.W. (2008). The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey. Oncogene 27, 5398-5415.
DOI
|
17 |
Ko, J.K., Choi, K.H., Zhao, X., Komazaki, S., Pan, Z., Weisleder, N., and Ma, J. (2011). A versatile single-plasmid system for tissue-specific and inducible control of gene expression in transgenic mice. FASEB J. 25, 2638-2649.
DOI
|
18 |
Kunath, T. (2008). Transgenic RNA interference to investigate gene function in the mouse. Methods Mol. Biol. 461, 165-186.
DOI
|
19 |
Li, L., Liu, F., and Ross, A.H. (2003). PTEN regulation of neural development and CNS stem cells. J. Cell. Biochem. 88, 24-28.
DOI
|
20 |
Kwon, C.H., Zhu, X., Zhang, J., Knoop, L.L., Tharp, R., Smeyne, R.J., Eberhart, C.G., Burger, P.C., and Baker, S.J. (2001). Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat. Genet. 29, 404-411.
DOI
|
21 |
Matthess, Y., Kappel, S., Spankuch, B., Zimmer, B., Kaufmann, M., and Strebhardt, K. (2005). Conditional inhibition of cancer cell proliferation by tetracycline-responsive, H1 promoter-driven silencing of PLK1. Oncogene 24, 2973-2980.
DOI
|
22 |
Miething, C., Scuoppo, C., Bosbach, B., Appelmann, I., Nakitandwe, J., Ma, J., Wu, G., Lintault, L., Auer, M., Premsrirut, P.K., et al. (2014). PTEN action in leukaemia dictated by the tissue microenvironment. Nature 510, 402-406.
DOI
|
23 |
Orloff, M.S., and Eng, C. (2008). Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome. Oncogene 27, 5387-5397.
DOI
|
24 |
Premsrirut, P.K., Dow, L.E., Kim, S.Y., Camiolo, M., Malone, C.D., Miething, C., Scuoppo, C., Zuber, J., Dickins, R.A., Kogan, S.C., et al. (2011). A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 145, 145-158.
DOI
|
25 |
Song, M.S., Salmena, L., and Pandolfi, P.P. (2012). The functions and regulation of the PTEN tumour suppressor. Nature reviews. Mol. Cell Biol. 13, 283-296.
DOI
|
26 |
Tiscornia, G., Tergaonkar, V., Galimi, F., and Verma, I.M. (2004). CRE recombinase-inducible RNA interference mediated by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101, 7347-7351.
DOI
|
27 |
Wilson, R.C., and Doudna, J.A. (2013). Molecular mechanisms of RNA interference. Annu. Rev. Biophys. 42, 217-239.
DOI
|
28 |
Wiznerowicz, M., Szulc, J., and Trono, D. (2006). Tuning silence: conditional systems for RNA interference. Nat. Methods 3, 682-688.
DOI
|